Skip to navigation Skip to content



National MS Society-Supported Researchers Report Success Protecting Nervous System in Mice

May 29, 2015

Researchers funded by the National MS Society and the Illinois Lottery administered a compound that naturally occurs in the brain, called lanthionine ketamine-ester (LKE), to mice with an MS-like disease. The treatment reduced signs of the disease and also reduced nerve degeneration . If these results hold up in future research, it could lead to clinical trials with people with MS to test the ability of LKE to protect the nervous system from damage and stop MS progression.

Read more on MS News Today.
Watch a webcast on Promising research to repair, protect and restore the nervous system

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.